Northwest Biotherapeutics (NWBO) EBITDA (2010 - 2026)
Northwest Biotherapeutics' EBITDA was -$10.83 million in Q2 2026, compared with -$14.33 million a year earlier.
Powered by 
Analysis
Northwest Biotherapeutics (NWBO) EBITDA (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, Northwest Biotherapeutics' EBITDA was -$47.61 million through Jun 30, 2026; for FY2025, it came in at -$57.85 million.
- In earlier years, EBITDA was -$64.76 million in FY2024, -$53.98 million in FY2023, -$65.93 million in FY2022 and -$52.38 million in FY2021.
- Quarterly EBITDA has moved between -$20.58 million (Q2 2022) and -$9.95 million (Q3 2021) over five years.
- Per Business Quant data, NWBO's EBITDA in the three quarters before Q2 2026 was -$10.13 million (Q1 2026), -$12.78 million (Q4 2025) and -$13.87 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 12.29 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 8.30 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 8.33 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 999.00 Mn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 5.09 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 4.63 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | -9.70 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 5.89 Bn |
| 10 | Northwest Biotherapeutics | 248.01 Mn | 238.03 Mn | - | -10.71 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -10.71 Mn |
| Mar 31, 2026 | -9.85 Mn |
| Dec 31, 2025 | -12.16 Mn |
| Sep 30, 2025 | -13.46 Mn |
| Jun 30, 2025 | -13.80 Mn |
| Mar 31, 2025 | -16.54 Mn |
| Dec 31, 2024 | -17.20 Mn |
| Sep 30, 2024 | -13.81 Mn |
| Jun 30, 2024 | -16.54 Mn |
| Mar 31, 2024 | -14.74 Mn |
| Dec 31, 2023 | -14.35 Mn |
| Sep 30, 2023 | -12.68 Mn |
| Jun 30, 2023 | -12.50 Mn |
| Mar 31, 2023 | -12.08 Mn |
| Dec 31, 2022 | -17.20 Mn |
| Sep 30, 2022 | -14.71 Mn |
| Jun 30, 2022 | -19.88 Mn |
| Mar 31, 2022 | -11.38 Mn |
| Dec 31, 2021 | -10.01 Mn |
| Sep 30, 2021 | -9.59 Mn |
API Access
Northwest Biotherapeutics EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=NWBO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "NWBO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=NWBO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();